Market map · United Kingdom
Precision medicine market map: United Kingdom
22 precision medicine startups based in the United Kingdom that have raised money in rounds we track, placed in 3 segments by what each says it does. Together they have raised $404M; the biggest segment is companion diagnostics and biomarkers.
Funding by segment
- Companion diagnostics and biomarkers$109M11
- Precision oncology$111M7
- Data and AI platforms$184M4
Where they are based
- United Kingdom22$404M
United KingdomFounded
3 without a founding year on record.
Total raised
- Under $1M4
- $1M to $10M8
- $10M to $50M6
- $50M to $250M4
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
19 of 22 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United Kingdom22
Startups by country, 1 country in all.
Segment by segment
Companion diagnostics and biomarkers
11 startups · $109M raised
BrainomixBrainomix Limited is a medical technology and digital health company based in Oxford, England.United Kingdom$52M
Cumulus NeuroscienceCumulus Neuroscience is a neurotechnology and biotechnology company based in Belfast, Northern Ireland, founded in 2015.United Kingdom$19M
ChronomicsTech-bio company, providing access to a ‘bio-infrastructure’ to simplify and speed-up the use of biomarkers to improve everyday decisions.United Kingdom$14M
thymiaThymia is a London-based health technology startup founded in 2020, recognized as the world’s first foundational voice biomarker platform.United Kingdom$8.4M
Axo LongevityAxo Longevity is a high-performance longevity platform based in Europe, founded in 2025.United Kingdom$5.0M
SEQUENTIALSequential is a biotechnology company focused on personal care and health research.United Kingdom$3.5M
Guilford Street LaboratoriesGuilford Street Laboratories (GSL) is a biotechnology company based in London, founded in 2023 as a spin-out from University ColleUnited Kingdom$3.2M
Droplet ScientificDroplet Scientific Portable and wearable analyzers for continuous, real-time biomarker monitoring.United Kingdom$2.0M
Precision oncology
7 startups · $111M raised
BiofidelityBiofidelity is a genomic technology company based in Cambridge, UK, with a focus on enhancing cancer care through precision mediciUnited Kingdom$50M
CoSyne TherapeuticsCoSyne Therapeutics is an AI-driven drug discovery company based in London, UK, founded in 2021.United Kingdom$24M
MacomicsMacomics Ltd is a biotechnology and immuno-oncology company based in Edinburgh, Scotland, with additional facilities in Cambridge, UK.United Kingdom$21M
AbcodiaAbcodia is a biotechnology company that focuses on the discovery and validation of biomarkers for cancer screening.United Kingdom$10M
Mursla BioMursla Bio is a biotechnology company based in Cambridge, UK, with a secondary location in Boston, MA, USA.United Kingdom$5.0M
RareCanRareCan is a UK digital health company dedicated to supporting individuals with rare and less common cancers.United Kingdom$456K
Oxford Cancer BiomarkersOxford Cancer is developing and commercialising a suite of colorectal cancer biomarker tests to improve the current treatment pathway.United Kingdom$167K
Data and AI platforms
4 startups · $184M raised
GenomicsGenomics Ltd, founded in 2014 in Oxford, UK, is a global techbio and precision medicine company.United Kingdom$93M
LifebitLifebit is a precision medicine software company founded in 2017, based in London, with additional operations in Athens.United Kingdom$60M
Sano GeneticsSano Genetics is a biotechnology and software company based in Cambridge, UK, founded in 2017.United Kingdom$26M
TuuneTuune is a precision medicine femtech startup founded in 2017, focused on providing personalized contraception solutions for women.United Kingdom$4.6M
How this map is made. Every startup here has raised money in rounds we track, and is based in United Kingdom. It joins the map when its sectors, read from its rounds, or the opening of its own description say it works in precision medicine, and goes to the first segment whose words it carries. Each segment shows its best-funded first. Rebuilt nightly; updated 15 November 2026.
More market maps
All mapsWho backs precision medicine?
Open any company for its rounds and investors, or search the investors behind these startups in the app, with filters, lists and exports.